UNSPSC 41141703: Aldehyde urobilinogen determination reagents

In this classification, this entry connotes a reagent made of Aldehyde urobilinogen determination used in clinical chemistry testing.

UNSPSC 41141703 Aldehyde urobilinogen determination reagents is a Commodity code that captures laboratory diagnostic reagents and consumables state and local health agencies procure for infectious disease surveillance, pathogen detection, and drinking water quality testing. Recent activity shows health departments soliciting next-generation sequencing kits for respiratory pathogen and SARS-CoV-2 detection, whole genome sequencing reagents for foodborne illness outbreak investigation, solid phase extraction disks for EPA-compliant drinking water analysis, culture media for pathogenic organism identification, and specialized chemistry standards for chromatography-based contaminant analysis. The code's nominal scope — urobilinogen determination — does not align with the actual procurement activity under it, which centers on microbial genomics, infectious disease surveillance, and environmental testing rather than clinical urinalysis chemistry.

The issuing bodies are predominantly state health departments and public health laboratories: the Texas Health and Human Services Commission and Department of State Health Services have posted the majority of recent solicitations (five IFBs since February 2026), the Mississippi State Department of Health has issued sole source procurements for genomics reagents (two notices in April 2026), and the State of California has posted two RFBs for diagnostic reagents. The University of Texas Health Science Center at San Antonio issued an RFP for a comprehensive biotech and clinical diagnostics catalog in May 2026, and the City of Philadelphia requested quotes for extraction columns in May 2026. Geographic concentration is heaviest in Texas, with activity also visible in Mississippi and California. Representative recent opportunities include Texas HHS0017272 for next-generation sequencing consumables (respiratory pathogen detection kits, IFB, due May 19, 2026); Mississippi 3150006813 for Illumina whole genome sequencing kits and reagents (sole source, objection deadline May 14, 2026); and Texas HHS0017287 for Atlantic ReadyDisk HC-C18 solid phase extraction disks for drinking water testing under EPA methods (IFB, due May 13, 2026). Contract values range from the City of Philadelphia's $43,000 micro purchase to Mississippi's $393,667.98 sole source for Illumina sequencing supplies and Texas HHS0016980's Clear Labs sequencer system (historical fiscal year 2022 reference of $264,950). Most Texas procurements specify firm, fixed pricing with optional one-year extensions; all require extensive HHS-specific certifications addressing debarment, human trafficking prohibitions, E-Verify compliance, and Texas statutory policy requirements.